Effect of Sitagliptin on Lipid Profile in Patients With Type 2 Diabetes Mellitus

BACKGROUND: Animal studies have demonstrated that an inhibition of DPP-4 has an impact on the secretion of cholesterol and apoB by the small intestine. However, there is no consensus about the changes of the lipid profile following administration of sitagliptin. METHODS: Accordingly, we treated pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Shigematsu, Erina, Yamakawa, Tadashi, Kadonosono, Kazuaki, Terauchi, Yasuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125327/
https://www.ncbi.nlm.nih.gov/pubmed/25110536
http://dx.doi.org/10.14740/jocmr1889w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125327/
https://www.ncbi.nlm.nih.gov/pubmed/25110536
http://dx.doi.org/10.14740/jocmr1889w

Ejemplares similares